PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2014.20.1.38201420138The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patientsHee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kimhttp://synapse.koreamed.org/pdf/10.3350/cmh.2014.20.1.38, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2014.20.1.38, http://www.e-cmh.org/upload/pdf/cmh-20-38.pdf
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2008.03657.x2008279790-797Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infectionG. BORRONI, M. ANDREOLETTI, M. A. CASIRAGHI, R. CERIANI, P. GUERZONI, B. OMAZZI, N. TERRENI, F. SALERNOhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2008.03657.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2008.03657.x/fullpdf
Therapeutics and Clinical Risk Management10.2147/tcrm.s20932008Volume 4789-796Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patientsSteven Herrinehttps://www.dovepress.com/getfile.php?fileID=3295, https://www.dovepress.com/getfile.php?fileID=3295
Pharmacogenomics and Personalized Medicine10.2147/pgpm.s446120101Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirinOlav Dalgardhttps://www.dovepress.com/getfile.php?fileID=5885
Gastroenterology10.1016/s0016-5085(09)63650-720091365A-79113 Impact of Diet and Exercise Intervention On Insulin Resistance and Early Virological Response to Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis CYasunori Kawaguchi, Toshihiko Mizuta, Takuya Kuwashiro, Noriko Oza, Hirokazu Takahashi, Yuichiro Eguchi, Iwata Ozaki, Kazuma Fujimotohttps://api.elsevier.com/content/article/PII:S0016508509636507?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508509636507?httpAccept=text/plain
Current Hepatitis Reports10.1007/s11901-006-0014-z200653114-120Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonrespondersMitchell L. Shiffmanhttp://link.springer.com/content/pdf/10.1007/s11901-006-0014-z.pdf, http://link.springer.com/article/10.1007/s11901-006-0014-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11901-006-0014-z
Pakistan BioMedical Journal10.52229/pbmj.v2i1.28201921Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3aWaqas Gulzar, Zafar Niaz, Sami Ullah Mumtaz, Somia Iqtadar, Tayyeba Komal, Sajid AbaidUllahhttps://pakistanbmj.com/journal/index.php/pbmj/article/download/28/6, https://pakistanbmj.com/journal/index.php/pbmj/article/download/28/6
Journal of Hepatology10.1016/s0168-8278(10)60774-x201052S300772 COMBINATION USE OF INTERFERON-BETA WITH DOUBLE FILTRATION PLASMAPHERESIS FOR THE CHRONIC HEPATITIS C PATIENTS WITH REFRACTORY TO PEGYLATED INTERFERON A-2B / RIBAVIRIN COMBINATION THERAPYK. Takaguchi, N. Baba, T. Seno, T. Naganohttps://api.elsevier.com/content/article/PII:S016882781060774X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S016882781060774X?httpAccept=text/plain
Hepatology Research10.1111/j.1872-034x.2010.00711.x20104010963-970Impact of early elevation of serum bilirubin during treatment with pegylated interferon and ribavirin in patients with chronic hepatitis CMasatoshi Ishigami, Kazuhiko Hayashi, Yoshiaki Katano, Akihiro Itoh, Yoshiki Hirooka, Hidemi Gotohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2010.00711.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2010.00711.x/fullpdf
Journal of Hepatology10.1016/s0168-8278(11)61144-6201154S4511142 INCREASED BONE MINERAL DENSITY IN CHRONIC HEPATITIS C PATIENTS AFTER TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATIONC. Bunchorntavakul, W. Chotiyaputta, S. Nimanong, S. Chainuvati, P. Charatcharoenwitthaya, S. Sriussadaporn, T. Tanwandeehttps://api.elsevier.com/content/article/PII:S0168827811611446?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827811611446?httpAccept=text/plain